FDA approves topical ruxolitinib for atopic dermatitis, first JAK inhibitor for this indication in the U.S.September 21, 2021Dermatology
Medicare patients’ cost burden for specialty psoriasis, PsA drugs remains highSeptember 15, 2021DermatologyRheumatology
New guidance on preventing cutaneous SCC in solid organ transplant patientsSeptember 10, 2021DermatologyOncologyMixed Topics
FDA inaction on hair loss drug’s suicide, depression, erectile dysfunction risk sparks lawsuitSeptember 9, 2021DepressionDermatologyMental Health
Biologic benefit in psoriasis might extend to arthritis preventionAugust 30, 2021DermatologyRheumatology
NIH to study COVID vaccine booster in people with autoimmune diseaseAugust 27, 2021COVID-19 UpdatesVaccinesRheumatologyDermatologyNeurology
FDA okays difelikefalin for dialysis-associated pruritus in patients with CKDAugust 26, 2021NephrologyDiabetesDermatology
Age, distance from dermatology clinic <p>predict number of melanomas diagnosedAugust 12, 2021Business of MedicineDermatology
Which AK treatment has the best long-term efficacy? A study reviews the dataAugust 12, 2021Dermatology
